Immunic (IMUX) Shares Outstanding (2013 - 2026)

Immunic has reported Shares Outstanding (Entity) for 14 years, with the latest figure at $30.1 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 234.29% year-over-year to $30.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.1 million (up 234.29% YoY) and the FY2025 annual result came in at $15.6 million, up 72.7% from the prior year.
• Shares Outstanding (Entity) advanced to $30.1 million in Q1 2026 per IMUX's latest filing, from $15.6 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $30.1 million in Q1 2026 and troughed at $2.9 million in Q1 2022.
• A 5-year average of $9.0 million and a median of $9.0 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Entity) grew 0.08% in 2025, then jumped 234.29% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $3.2 million in 2022, then jumped by 41.98% to $4.5 million in 2023, then surged by 99.55% to $9.0 million in 2024, then soared by 72.7% to $15.6 million in 2025, then surged by 93.57% to $30.1 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $30.1 million, $15.6 million, and $19.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.